The BEAMER project, sponsored by the Technical University of Madrid, addresses the critical issue of medication adherence, which affects approximately 50% of patients globally. By leveraging the B-COMPASS model, the project seeks to improve patient engagement and adherence, potentially reducing healthcare costs and improving health outcomes. The involvement of multiple pharmaceutical companies, including Pfizer, Merck KGaA, and Janssen, indicates strong industry interest and potential for collaboration. The project's success could position it as a valuable tool for healthcare providers and payers, enhancing market access and competitive advantage in the digital health space focused on patient adherence solutions.